Platinum Investment Management LTD Fulcrum Therapeutics, Inc. Transaction History

Platinum Investment Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$14.0 - $28.44 $2.13 Million - $4.33 Million	-152,186 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$8.09 - $12.0 $555,265 - $823,632	68,636 Added 82.15%	152,186 $1.6 Million
Q2 2020 Aug 06, 2020	SELL	$9.11 - $22.06 $109,165 - $264,344	-11,983 Reduced 12.54%	83,550 $1.53 Million
Q1 2020 May 15, 2020	SELL	$9.49 - $21.26 $410,290 - $919,154	-43,234 Reduced 31.16%	95,533 $1.14 Million
Q4 2019 Feb 13, 2020	BUY	$4.46 - $18.14 $284,400 - $1.16 Million	63,767 Added 85.02%	138,767 $2.31 Million
Q3 2019 Nov 14, 2019	BUY	$6.64 - $14.89 $498,000 - $1.12 Million	75,000 New	75,000 $498,000

135

59.5M

4.32M

307K

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $196M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.